Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 3, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 5, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-003311
Filed / recorded
Mar 5, 2026, 10:25 PM UTC
Added to OQRO
Oct 1, 2026, 11:17 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
PFIZER INC
Issuer CIK
78003
Ticker
PFE
Reporting person
Lidia Fonseca
Relationship
Officer
Officer title
Executive Vice President
Security
Stock Appreciation Rights
Table
Derivative (Table II)
Transaction date
Mar 3, 2026
Transaction code
A
Shares / units
82,284
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
82,284
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.